- Poster presentation
- Open Access
Fibrotic content of LV myocardium quantified by CMR characterizes left atrial sizes and total left atrial emptying function incremental to LV functional parameters and LV myocardial mass index in patients with hypertrophic cardiomyopathy
© Chen et al; licensee BioMed Central Ltd. 2012
- Published: 1 February 2012
- Leave Atrial
- Hypertrophic Cardiomyopathy
- Leave Atrial Volume
- Diastolic Heart Failure
- Leave Atrial Size
Fibrotic burden of LV myocardium quantified by CMR provides additional information about LA size and mechanics than morphological severity of LV hypertrophy measured by LV mass index alone.
Progressive myocardial stiffness of the LV in patients with hypertrophic cardiomyopathy (HCM) impedes early diastolic filling and left atrial (LA) emptying functions. Over time, LA of patients with HCM progressively dilates and undergoes structural and functional remodeling with serious cardiac events such as development of atrial fibrillation and diastolic heart failure despite optimal medical therapy.
We studied 65 HCM patients (46 men, mean age 39±14years, mean LVEF 63±9%) with CMR. The fibrotic content of the LV myocardium (FIMeanSeg, averaged over 18 segments) was obtained using serial R1 mapping by cine-IR method before and up to 30 minutes after contrast injection. LA volumes and LA emptying function across 3 phases of the cardiac cycles, and LV function were also quantified. We sought to determine the strongest variables that predispose the patients to have LA dilatation and impaired LA emptying function.
Correlation between LV fibrotic index and left atrial size or function
Best Overall Model for Maximal Left Atrial Size
Best Overall Model for Total Left Atrial Emptying Function
LV mass index (g/m2)
FIMeanSeg provides independent association with LV volume beyond knowledge of ventricular functional parameters and severity of ventricular hypertrophy by LV mass. This novel method may add to the current characterization of impaired diastolic function in HCM patients and may have prognostic implications.
Yucheng Chen got the salary from China Scholarship Council.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.